Literature DB >> 12841647

Interruption of signal transduction between G protein and PKC-epsilon underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts.

Takayuki Miki1, Tetsuji Miura, Masaya Tanno, Jun Sakamoto, Atsushi Kuno, Satoshi Genda, Tomoaki Matsumoto, Yoshihiko Ichikawa, Kazuaki Shimamoto.   

Abstract

We have recently shown that the protective mechanism of ischemic preconditioning (PC) is impaired in the myocardium that survived infarction and underwent postinfarct ventricular remodeling. In this study, we examined the hypothesis that failure of PC to activate PKC-epsilon underlies the refractoriness of the remodeling heart to PC. Circumflex coronary arteries were ligated in rabbits to induce infarction and subsequent ventricular remodeling, and only sham operations were performed in controls. Hearts were isolated before (i.e. 4 days later) or after (i.e. 2 weeks later) remodeling of the left ventricle and used for isolated buffer-perfused heart experiments. Myocardial infarction was induced in isolated hearts by 30 min global ischemia/2 h reperfusion, and its size was measured by tetrazolium staining. Using separate groups of hearts, tissue biopsies were taken before and after PC, and PKC translocation was assessed by Western blotting. Areas infarcted in vivo by coronary ligation (CL) were excluded from subsequent infarct size/PKC analyses. In the hearts 4 days after CL, PC with 2 cycles of 5 min ischemia/5 min reperfusion induced PKC-epsilon translocation from cytosol to particulate fractions and limited infarct size to 40% of control value. In the hearts remodeled 2 weeks after CL, PC failed to induce PKC-epsilon translocation and infarct size limitation. In this group, PKC activity and hemodynamic responses to adenosine were similar to those in sham-operated controls. When remodeling after CL was prevented by valsartan infusion (10 mg/kg/day), an angiotensin II type 1 (AT1) receptor blocker, PC could induce both infarct limitation and PKC-epsilon translocation. The present results suggest that persistent activation of AT1 receptors during remodeling disturbed the PC signaling between G proteins and PKC-epsilon, which underlies the refractoriness of the remodeled myocardium to PC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841647     DOI: 10.1023/a:1024124016053

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Role of angiotensin in cardioprotective effect of ischemic preconditioning.

Authors:  A Sharma; M Singh
Journal:  J Cardiovasc Pharmacol       Date:  1999-05       Impact factor: 3.105

2.  Role of the angiotensin II type 1 receptor in preconditioning against infarction.

Authors:  A Nakano; T Miura; N Ura; K Suzuki; K Shimamoto
Journal:  Coron Artery Dis       Date:  1997-06       Impact factor: 1.439

3.  Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

Authors:  T Miki; T Miura; A Tsuchida; A Nakano; T Hasegawa; T Fukuma; K Shimamoto
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

4.  Contribution of both the sarcolemmal K(ATP) and mitochondrial K(ATP) channels to infarct size limitation by K(ATP) channel openers: differences from preconditioning in the role of sarcolemmal K(ATP) channels.

Authors:  M Tanno; T Miura; A Tsuchida; T Miki; Y Nishino; Y Ohnuma; K Shimamoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-09       Impact factor: 3.000

5.  Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

Authors:  T Pain; X M Yang; S D Critz; Y Yue; A Nakano; G S Liu; G Heusch; M V Cohen; J M Downey
Journal:  Circ Res       Date:  2000-09-15       Impact factor: 17.367

6.  Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.

Authors:  P Ping; J Zhang; Y Qiu; X L Tang; S Manchikalapudi; X Cao; R Bolli
Journal:  Circ Res       Date:  1997-09       Impact factor: 17.367

7.  Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes.

Authors:  G S Liu; M V Cohen; D Mochly-Rosen; J M Downey
Journal:  J Mol Cell Cardiol       Date:  1999-10       Impact factor: 5.000

8.  Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B.

Authors:  R A Kloner; T Shook; E M Antman; C P Cannon; K Przyklenk; K Yoo; C H McCabe; E Braunwald
Journal:  Circulation       Date:  1998-03-24       Impact factor: 29.690

9.  Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.

Authors:  G S Liu; S C Richards; R A Olsson; K Mullane; R S Walsh; J M Downey
Journal:  Cardiovasc Res       Date:  1994-07       Impact factor: 10.787

10.  Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning.

Authors:  Yoshito Ohnuma; Tetsuji Miura; Takayuki Miki; Masaya Tanno; Atsushi Kuno; Akihito Tsuchida; Kazuaki Shimamoto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

View more
  3 in total

1.  Tolerance to ischaemic injury in remodelled mouse hearts: less ischaemic glycogenolysis and preserved metabolic efficiency.

Authors:  Waleed G T Masoud; Osama Abo Al-Rob; Yang Yang; Gary D Lopaschuk; Alexander S Clanachan
Journal:  Cardiovasc Res       Date:  2015-07-06       Impact factor: 10.787

Review 2.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

Review 3.  Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection.

Authors:  Zesergio Melo; Cecilia Ishida; Maria de la Paz Goldaraz; Rocio Rojo; Raquel Echavarria
Journal:  Noncoding RNA       Date:  2018-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.